SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maul Coin

Maul Coin is generating buzz among traders who are attracted to its active developer engagement and the community's push to build organic momentum, despite the project's early stage and lack of an official chart. Investors are actively discussing the potential for a significant breakout, emphasizing the need for sustained volume and broader social media promotion to move the token toward mainstream visibility.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

Rage Guy is gaining traction as investors rally behind its status as an iconic, original meme, with the community actively promoting its restored meme-generation tools and historical roots on the Solana network. Supporters are focused on long-term conviction and 'bagwork,' positioning the token as a primary contender in the current meme coin cycle by emphasizing its deep cultural heritage and utility for content creation.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy (MULN CRYPTO) is currently trending as members debate its viability, with many in the community labeling it a pump-and-dump scheme or comparing it to the Mullen Automotive stock decline. While some users attempt to rally interest through community-led narratives and crypto-market speculation, others are actively warning investors to exit to avoid potential financial losses.

iShares Inc. - iShares MSCI Mexico ETF

iShares MSCI Mexico ETF

Investors are actively debating the long-term viability of Mexico as a manufacturing hub, with some noting its strategic importance in nearshoring supply chains while others warn of socio-economic decay and political risks. The community is focused on the impact of trade tariffs and US-Mexico relations on the performance of $EWW.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

The XRP community remains deeply divided, with some investors accumulating tokens in anticipation of regulatory clarity and institutional adoption, while others express frustration over long-term price stagnation and perceived lack of progress. Debates are currently fueled by speculation surrounding the Clarity Act and the expansion of Ripple's payment infrastructure, leading to a polarized environment between optimistic long-term holders and disillusioned skeptics.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is trending as investors monitor its development as a rare earth metals processor amid increasing urgency for U.S.-aligned supply chains. The community is actively debating the stock's long-term potential in the defense sector, with heavy discussions focused on the company's advisory board appointments, defense-related contracts, and the risks versus rewards associated with future production timelines.

Bitcoin SV (BSV) emerged following a hard fork of the Bitcoin Cash (BCH) blockchain in 2018, which had in turn forked from the BTC blockchain a year earlier. The goal of Bitcoin SV is to fulfil the original vision of the Bitcoin protocol and design as described in Satoshi Nakamoto’s white paper, early Bitcoin client software and known Satoshi writings. BSV aims to offer scalability and stability in line with the original description of Bitcoin as a peer-to-peer electronic cash system, as well as deliver a distributed data network that can support enterprise-level advanced blockchain applications. To this end, it has removed artificial block size limits and re-enabled Script commands and other technical capabilities which had been historically disabled or restricted by the protocol developers of the BTC blockchain. This allows the network to process tens of thousands of transactions per second while maintaining extremely low transaction fees for micropayments, in addition to offering advanced capabilities such as tokens, smart contracts, computation and other data use cases. The BSV network is unique in its capacity for unbounded on-chain scaling while also being more aligned with the original design of Bitcoin than any other blockchain.

Bitcoin SV

Bitcoin SV is facing significant volatility as the community reacts to ongoing court proceedings involving Craig Wright and his claims regarding the identity of Satoshi Nakamoto. Investors are debating the project's long-term utility and its role as the 'original protocol' versus the broader market dominance of BTC, with many tracking court updates as a key catalyst for potential price movements.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is currently a focal point for investors due to clinical progress with its ITK inhibitor, soquelitinib, which has generated buzz for its potential to deliver durable, disease-modifying outcomes in atopic dermatitis and oncology. Community sentiment remains highly polarized, with intense debate between bulls anticipating a strategic buyout or short squeeze and skeptics emphasizing the inherent risks of a clinical-stage biotech and the potential for share dilution.

ETF Series Solutions - ESS U.S.Global Jets ETF

US Global Jets ETF

Airline stocks are facing renewed volatility as the sector grapples with potential operational disruptions, fuel cost pressures, and broader economic uncertainty. The community is actively debating the sustainability of travel demand and debating whether the recent price action offers a contrarian value opportunity or a warning of deeper industry headwinds.

Invesco Exchange-Traded Fund Trust II - Invesco Solar ETF

Invesco Solar ETF

Invesco Solar ETF is navigating heightened market volatility as investors weigh the impact of shifting political landscapes and policy rhetoric on long-term renewable energy demand. The community is actively debating the sector's resilience, with many pointing to the structural necessity of solar to support the power-intensive growth of AI and data center infrastructure despite short-term regulatory headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Indian equity markets ended a range-bound session on a subdued note on Wednesday, with the Nifty holding the 25,200 level.The markets are likely to open flat to slightly negative on Thursday, tracking mixed global cues.&nbsp;The focus remains on any announcement regarding an interim US–India trade deal, following a signal from US President Donald Trump of some progress. The agreement is expected to be similar to the recent US-Indonesia agreement, according to reports.The GIFT Nifty, a key early indicator for the Nifty 50, was 0.03% lower at 25,273.5.With the earnings season in full swing, here are the stocks to watch in today’s trade.Expected Q1 Results: Axis Bank, Wipro, Jio Financial, LTIMindtree, HDFC AMC, 360 ONE WAM, Alok Industries, Ceat, Clean Science and Technology, Indian Hotels Company, Polycab India, Shoppers Stop, South Indian Bank, Tata Communications, Waaree Renewable Technologies, and others.Tech Mahindra: The IT company reported a 33.9% rise in Q1FY26 net profit to ₹1,140.6 crore, with revenue growing 2.65% to ₹13,351.2 crore.L&amp;T Technology Services (LTTS): Saw a marginal 0.66% increase in Q1FY26 net profit to ₹315.7 crore, while revenue rose 16.4% to ₹2,866 crore.Angel One: Q1FY26 net profit plunged 61% to ₹114.5 crore, with revenue declining 18.8% to ₹1,140.5 crore.Le Travenues Technology: Ixigo reported a 27.5% rise in Q1FY26 profit to ₹18.9 crore, alongside a 72.9% surge in revenue to ₹314.5 crore.SBI: To raise up to ₹25,000 crore through a share sale to institutional investors. The floor price of ₹811.05 per share is below its last closing price of ₹830.5.Indian Hotels (IHCL): Invested over ₹165 crore to acquire 3.3 lakh equity shares in its wholly-owned arm ELEL Hotel and Investment through a rights issue, aiming to develop the Taj Bandstand project in Bandra.Maruti Suzuki: Announced standardization of six airbags in the Ertiga and Baleno, leading to a 1.4% and 0.5% ex-showroom price hike, respectively, effective July 16.Godrej Properties: Forays into Raipur with a 50-acre land acquisition to develop premium plotted residential units totaling 9.5 lakh sq ft.Hindustan Zinc: Received a LoI from the Ministry of Mines, selecting it as the preferred bidder for a composite license in Rajasthan’s 1,841.25-hectare Jhandawali–Satipura Potash and Halite block.Zydus Lifesciences: Its Matoda facility received zero observations following a USFDA remote assessment for Atorvastatin Calcium Tablets, and the site was recommended for approval.Emcure Pharmaceuticals: Signed an exclusive distribution agreement with Sanofi India for oral anti-diabetic drugs like Amaryl and Cetapin in India.Reliance Power: Approved plans to raise up to ₹9,000 crore, including ₹6,000 crore via QIP, follow-on public offer, or both, and ₹3,000 crore through NCDs.NTPC: The government allowed NTPC to invest up to ₹20,000 crore to expand its renewable energy capacity to 60 GW by 2032, significantly over the earlier limit of ₹7,500 crore.NLC India: Received government approval to invest ₹7,000 crore via its subsidiary NIRL to boost its renewable energy capacity to 32 GW by 2047.JSW Hydro Energy: The Supreme Court upheld Himachal Pradesh’s right to 18% free power from JSW Hydro Energy’s 1,045 MW Karcham Wangtoo project, overturning a High Court order that had capped it at 13%.HDFC Bank: HDFC Bank will consider a bonus issue and special interim dividend at its board meeting on July 19, subject to shareholder approval.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

The digital broadcast on the facade of the Bombay Stock Exchange (BSE) displays the benchmark share index SENSEX crossing 32,000 points, on July 13, 2017 in Mumbai, India. (Photo by Kunal Patil/Hindustan Times via Getty Images)

Trading Radar For July 17: SBI, Tech Mahindra, Indian Hotels, Angel One, and Hindustan Zinc Are On The Watchlist

Axis Bank, Wipro, and Jio Financial are among the many companies  expected to report their quarterly earnings later in the day.

Equity

Indian equity markets ended slightly lower on Wednesday, but remain rangebound as investors cautiously await developments around the US-India trade deal.The markets are likely to open flat to slightly negative on Thursday, tracking mixed global cues. The GIFT Nifty, an early indicator for the Nifty 50 index, was down 0.07% to 25,556.Here are the stocks to watch out for in today’s session.<a href="https://stocktwits.com/symbol/AMBUJACEM.NSE">Ambuja Cements</a>:&nbsp;Subsidiary ACC has commissioned a 1.5 MTPA brownfield grinding unit at Sindri, Jharkhand. This raises the total capacity to 104.45 MTPA.<a href="https://stocktwits.com/symbol/EIEL.NSE">Enviro Infra Engineers</a>:&nbsp;Its JV with AltoraPro Infrastructure has secured a ₹395.5 crore order from Maharashtra Industrial Development Corporation.<a href="https://stocktwits.com/symbol/RAILTEL.NSE">RailTel Corporation</a>:&nbsp;Received a ₹17.5 crore order in Chhattisgarh for network infrastructure and maintenance services.<a href="https://stocktwits.com/symbol/EMCURE.NSE">Emcure Pharmaceuticals</a>:&nbsp;The US FDA completed a pre-approval inspection of its Ahmedabad oncology facility with zero observations.<a href="https://stocktwits.com/symbol/BHARTIARTL.NSE">Bharti Airtel</a>:&nbsp;Has set up a step-down wholly owned subsidiary named Airtel Money.<a href="https://stocktwits.com/symbol/HCLTECH.NSE">HCL Technologies</a>:&nbsp;Partnered with Astemo Cypremos to develop autonomous and smart vehicle technologies.<a href="https://stocktwits.com/symbol/EMBASSY.NSE">Embassy Office Parks REIT</a>:&nbsp;APAC Company is expected to offload a 1.9% stake worth ₹681 crore via block deals, according to reports.<a href="https://stocktwits.com/symbol/INDOSOLAR.NSE">Indosolar</a>:&nbsp;Promoter Waaree Energies to sell up to 10 lakh shares (2.4% stake) via OFS with a floor price set at ₹265 per share.<a href="https://stocktwits.com/symbol/MUTHOOTFIN.NSE">Muthoot Capital Services</a>:&nbsp;Board approves the allotment of 12,500 NCDs worth ₹125 crore.<a href="https://stocktwits.com/symbol/ARISTO.NSE">Aristo Bio-Tech and Lifescience</a>:&nbsp;Received a ₹3.45 crore order from Sinochem India for glyphosate technical 95% w/w MIN supply.<a href="https://stocktwits.com/symbol/IDBI.NSE">IDBI Bank</a>:&nbsp;The Indian government is looking to complete the IDBI Bank stake sale by October, according to reports.<a href="https://stocktwits.com/symbol/NCLIND.NSE">NCL Industries</a>:&nbsp;Cement production declined by 5% to 6.34 lakh MT from 6.69 lakh MT, while dispatches fell 4% to 6.28 lakh MT from 6.57 lakh MT.Quarterly results expected today:&nbsp;Tata Consultancy Services (TCS), Tata Elxsi, Indian Renewable Energy Dev Agency (IREDA), Anand Rathi.<stembedurl>https://stocktwits.com/HarikaEnjamuri_SEBI_RA/message/620426071</stembedurl>SEBI-registered&nbsp;<a href="https://stocktwits.com/HarikaEnjamuri_SEBI_RA">analyst Harika Enjamuri</a> advised traders to keep a close eye on Hindustan Copper and RBL Bank, as they have been included in the F&amp;O ban list. For the Nifty index, she believes that unless it&nbsp;sustains above 25,501, it may face resistance with supports at 25,437 and 25,335.&nbsp;&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Trading Radar For July 10: TCS, Hindustan Copper, HCL Tech, Ambuja, Emcure, And Railtel Are On The Watchlist

Indian equity markets ended slightly lower on Wednesday, but remain rangebound as investors cautiously await developments around the US-India trade deal.

TCS, Hindustan Copper, HCL Tech, Ambuja, Emcure, And Railtel Are On The Watchlist

IT behemoth Tata Consultancy Services (TCS) is set to report its Q1 results later in the day. 


Indian markets remained rangebound at open, with the Nifty index hovering around the 25,400 level.At 09:40 a.m. IST, the&nbsp;<a href="https://stocktwits.com/symbol/NIFTY50.NSE">Nifty 50</a> traded 34 points lower at 25,371, while the Sensex fell 92 points to 83,147.&nbsp;Broader markets held in the green, with the Nifty Midcap index gaining 0.1%, while the Smallcap index traded flat.The retail sentiment on Stocktwits for Nifty has moved to ‘neutral’ from ‘bullish’.&nbsp;<figure class="image"><img style="aspect-ratio:803/104;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_04_095453_png_e373f3ecda.webp" alt="Screenshot 2025-07-04 095453.png" width="803" height="104"><figcaption>Nifty sentiment and message volume on July 4 as of 9:45 am IST. | source: Stocktwits</figcaption></figure>Sectorally, metals continued to trade under pressure, while real estate, FMCG and pharma stocks saw some buying.&nbsp;<a href="https://stocktwits.com/symbol/TRENT.NSE">Trent</a> was the top Nifty loser, falling 8% after management at its AGM stated that its fashion segment is expected to grow approximately 20% in Q1FY26E. Nuvama has downgraded the stock to ‘Hold’, and revised the target price to ₹5,884.&nbsp;Defense stocks rallied after the Defence Acquisition Council (DAC) approved the purchase of military hardware worth ₹1.05 lakh crore on Thursday.&nbsp;<a href="https://stocktwits.com/symbol/PARAS.NSE">Paras Defence</a> rose 6%, while&nbsp;<a href="https://stocktwits.com/symbol/GRSE.NSE">GRSE</a>,&nbsp;<a href="https://stocktwits.com/symbol/BEL.NSE">BEL</a>,&nbsp;<a href="https://stocktwits.com/symbol/BEML.NSE">BEML</a>, BDL, and Midhani gained between 1% to 2%.&nbsp;<a href="https://stocktwits.com/symbol/MARICO.NSE">Marico&nbsp;</a>rose 4%, while&nbsp;<a href="https://stocktwits.com/symbol/BAJFINANCE.NSE">Bajaj Finance</a> gained 3% as the street reacted to their quarterly updates.&nbsp;<a href="https://stocktwits.com/symbol/EMCURE.NSE">Emcure Pharma</a> fell 2% after 2.4% equity reportedly changed hands in a block deal.<a href="https://stocktwits.com/symbol/NBCC.NSE">NBCC</a> traded 2% higher after securing fresh orders worth ₹65.73 crore across Odisha and Karnataka. And&nbsp;<a href="https://stocktwits.com/symbol/GODAVARIB.NSE">Godavari Biorefineries</a> surged 5% after securing a patent in Europe for an anticancer molecule.&nbsp;In other news developments, the Securities and Exchange Board of India (SEBI) has banned Jane Street Group entities from participating in the Indian securities market.&nbsp;This decision comes after SEBI accused the US firm of market manipulation and issued an interim order to impound over ₹4,840 crore in alleged illegal gains from Jane Street. According to SEBI's order, Jane Street accrued ₹43,289 crore in profits from trading index options on Indian exchanges between January 1, 2023, and March 31, 2025.From a technical standpoint, SEBI-registered analysts on Stocktwits shared the trade setup.&nbsp;<a href="https://stocktwits.com/sameerpande">Sameer Pande</a> pegged Nifty support between 25,300 and 25,200, with resistance at 25,500-25,800.<stembedurl>https://stocktwits.com/sameerpande/message/619920125</stembedurl><a href="https://stocktwits.com/aymr_sebi_ra">A&amp;Y Market Research</a> sees the Nifty intraday resistance between 25,648 and 25,662, and support between 25,308 and 25,322. For Bank Nifty, they peg resistance at 57,028-57,071 and support at 56,467-56,510.<stembedurl>https://stocktwits.com/aymr_sebi_ra/message/619920601</stembedurl>Globally, Asian markets traded mixed, while crude oil prices remained stable. Investors are awaiting clarity on US President Donald Trump's tariff plans for various nations.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Indian Markets Rangebound; Trent Slides 8%, Defense Stocks Rally

 Retail sentiment for Nifty turned ‘neutral’ on Stocktwits, with analysts pegging support near 25,300. SEBI’s ban on Jane Street for alleged market manipulation adds regulatory pressure.

Indian equity markets may begin trade on a muted note, tracing mixed global cues. The GIFT Nifty was down 0.17% at 25516.7 while SGX Nifty was up 0.08% on Friday.Here are the stocks to watch out for in trade.Emcure Pharmaceuticals:&nbsp;Bain Capital’s affiliate, BC Investments IV, is reportedly planning to sell a 2.4% stake in Emcure via block deals worth approximately ₹551 crore.Piramal Pharma:&nbsp;The&nbsp;Carlyle Group is looking to offload up to 10% of its stake in the company through block trades, worth around ₹2,600 - 2,700 crore.Reliance Industries:&nbsp;Subsidiary Reliance Retail Ventures invests in UK-based global facial fitness and skincare company FACEGYM.Oil and Natural Gas Corporation (ONGC):&nbsp;ONGC partners with Japan’s Mitsui OSK Lines to build and operate two Very Large Ethane Carriers (VLECs).Vedanta: Lanjigarh Refinery posted record quarterly alumina production at 587 kt.&nbsp; However, Oil &amp; gas production declined 17% to 93.2 thousand barrels of oil equivalent per day.Torrent Pharmaceuticals: Torrent Pharma is set to acquire an additional 2.41% stake in JB Chemicals for ₹620 crore at ₹1,600 per share.NBCC (India):&nbsp;Won fresh orders worth ₹65.73 crore across Odisha and Karnataka, including project management consultancy services for multiple building projects.ICICI Lombard General Insurance: The Bombay High Court set aside a GST demand order of ₹1,728.9 crore and a penalty of ₹172.9 crore, directing a rehearing of the case. The insurer had filed a writ against the original order.Godavari Biorefineries:&nbsp;The company has been granted a patent in Europe for an anticancer molecule. The patent has been validated in Spain, the UK, and under the Unitary Patent system.Bajaj Finance:&nbsp;AUM climbed 25% higher to ₹4.41 lakh crore, while deposit base rose 15% to ₹72,100 crore. New loan books grew 23% to 13.49 million.Bank of Baroda: Global business grew 10.7% to ₹26.43 lakh crore compared to ₹23.87 lakh crore last year. Domestic deposits increased by 8.1% to ₹12.04 lakh crore.AWL Agri Business: The company reported a 21% YoY revenue increase in Q1 FY26, driven by higher edible oil realisations despite a 4% drop in overall volumes due to operational challenges.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com

(Photo by Indranil Aditya/NurPhoto via Getty Images)

July 4 Trade Radar: RIL, Emcure, ONGC, Torrent Pharma Are On The Watchlist

Watch out for major block deals in Emcure and Piramal Pharmaceuticals

Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. It focuses on therapeutic areas, such as the gynecology, cardiovascular, Vitamins, minerals and nutrients, Anti-invectives, gastrointestinal, blood related oncology/anti-neoplastics, HIV, neurology, respiratory and anti-diabetic therapeutic areas. The company offers a wide range of products and services under Formulations, Biologics and Active Pharmaceutical Ingredients. It produces pharmaceutical and biopharmaceutical products of a range of dosage forms, including oral solids, oral liquids, injectables including lipid, liposomal, lyophilized injectables, biologics, vaccines and complex APIs, including chiral molecules and cytotoxic products. Emcure Pharmaceuticals was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India.

EMCURE.NSE
Emcure Pharmaceuticals Ltd.

Feed

News

Sentiment

Fundamentals

Info

Latest EMCURE.NSE News

EMCURE.NSEEmcure Pharmaceuticals Ltd.